The Disease Susceptibility Genetic Test-Cardiovascular Protection

This test bases on biochip technology, evaluate the risk of three thrombotic diseases from the perspective of genetics, and detect the metabolic enzyme-related polymorphism loci and drug action targets of the three thrombotic drugs, guide the prevention of thrombotic diseases and rationally adjust the dosage of drugs, reduce side effects and improve cure rate.